Search results
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 1 day agoThe RS Rating is a 1-99 measure of a stock's 12-month performance. This means Moderna stock outranks...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 6 hours agoGyre is also considering treatments for chronic obstructive pulmonary disease, or COPD, pulmonary...
Pfizer to test third dose of COVID-19 vaccine in children
AOL· 2 days agoThe decision was made after an analysis showed the two-dose vaccine generated an immune response in...
NYC still giving new contracts for migrant services to controversial provider DocGo
New York Daily News· 44 minutes agoThe city is continuing to do business with DocGo, inking four new contracts with the controversial...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 1 day agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...
Largest U.S. Pension Sold Verizon, Disney, and Peloton Stock. It Bought Moderna.
Barrons.com· 5 days agoBoth shares beat the market in the first quarter, with Verizon... in the past week reported a strong...
Sanofi's New Cancer Drug Could Help Deliver a Big Payday
Motley Fool via Yahoo Finance· 1 day agoThe 10 stocks that made the cut could produce monster returns in the coming years. Consider when...
'Outgoing' boy left in a wheelchair and 'seeing monsters' after chickenpox bout
The US Sun· 2 days agoA DEVASTATED mum claims her son’s childhood has been “destroyed” after he suffered brain damage from...
The CDC Took Out 148 Pages of Essential Information
Mercola· 7 days agoPeople who receive a COVID-19 shot are at increased risk of myocarditis, or inflammation of the heart muscle,1 and pericarditis, which is inflammation of the outer lining of the heart. The public ...
Opko Health (OPK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 days agoIn oncology, we are pleased with GenPath's performance due to its innovative testing platform with an expanded hematological malignancy panel and very...